EC Clinical and Medical Case Reports

Leaky gut syndrome (LGS) is based on the concept that due to certain environmental factors and diseases the intestinal permeability enhanced. This is a hypothetical condition, that is still not being recognized in medical diagnosis. However, the causes and consequences of enhanced intestinal permeability have always been associated with the development of certain ailments, disorders and diseases in humans. Although the problems begin with the digestive system, it affects the entire body as well. While some of the reasons of leaky gut syndrome have been dysbiosis, poor diet, stress and the toxic overload in body, the symptoms developed as a consequence of the leaky gut in humans are as digestive disorders, seasonal and food allergies, bacterial overgrowth, chronic fatigue, skin and autoimmune diseases and arthritis with joint pain. The present paper deals with the study of nature and composition, maturation, mechanism of leaky gut development and the identity of gut microbiota in human.

 Keywords: Human Gut Microbiota; Composition; Maturation; Mechanism; Dysbiosis; Enhanced Intestinal Permeability; Leaky Gut

1. Visser J., et al. “Tight Junctions, intestinal permeability and autoimmunity celiac disease and type 1 diabetes paradigms”. Annals of the New York Academy of Sciences 1165 (2009): 195-205.
2. Thoma YM., et al. “Tight Junctions and the intestinal barrier”. Johnson LR., et al. (eds). Physiology of the gastrointestinal tract, Volume I. Academic Press (2012): 1043.
3. Matthew AO and Turner JR. “Intestinal permeability defects: Is it time to treat”. Clinical Gastroenterology and Hepatology 9 (2013): 1075-1083.
4. Camilleri M. “What is leaky gut? Clinical considerations in human”. Correct Opinion in Clinical Nutrition and Metabolic Care5 (2021): 473-482.
5. Liang L., et al. “Food, gut barrier dysfunction and related diseases: A new target for future individualized disease prevention and management”. Food Science and Nutrition 4 (2023): 1671-1704.
6. Qin J., et al. “A human gut microbial gene catalogue established by metagenomic sequencing”. Nature 7285 (2010): 59-65.
7. Rizzatti G., et al. “Proteobacteria: A common factor in human disease”. BioMed Research International (2017): 9351507.
8. Wang B., et al. “The human microbiota in health and disease”. Engineering1 (2017): 71-82.
9. Mitchelle YN., et al. “Endometriosis and irritable bowel syndrome: A systematic review and meta-analysis”. Frontiers in Medicine (Obstetrics and Gynecology) 9 (2022): 914356.
10. Zhu F., et al. “The microbiota-gut-brain axis in depression: The potential pathophysiological effect”. Nutrients 10 (2022): 2081.
11. Veres- Szekely A., et al. “Zonulin as a potential therapeutic target in microbiota Gut-Brain axis disorders: Encouraging result and emerging questions”. International Journal of Molecular Sciences 8 (2023): 7548.
12. Harkins CP., et al. “Manipulating the human microbiome to manage disease”. Journal of the American Medical Association 4 (2020): 303-304.
13. Stephen AM and Cummings JH. “The microbial contribution to human fecal mass”. Journal of Medical Microbiology 1 (1980): 45-56.
14. Zhang P. “Influence of foods and nutrition on the gut microbiome and implication for intestinal health”. International Journal of Molecular Sciences 17 (2022): 9588.
15. Munawar N., et al. “Hidden role of gut microbiome dysbiosis in schizophrenia: Antipsychotics or psychobiotics as therapeutics?” International Journal of Molecular Sciences 14 (2021): 7671.
16. Alou MT., et al. “Diet influence on the gut microbiota and dysbiosis related to nutritional disorders”. Human Microbiome Journal 1 (2016): 3-11.
17. King CH., et al. “Baseline human gut microbiota profile in healthy people and standard reporting template”. PLoS ONE9 (2019): e206484.
18. Turnbaugh PJ., et al. “The human microbiome project”. Nature 7164 (2007): 804-810.
19. Brussow H. “Microbiota and the human nature: know thyself”. Applied Microbiology International 1 (2014): 10-15.
20. Van Best N. “The nature of gut microbiota in early life: Origin and impact of pioneer species”. Doctoral thesis, Maastricht University. Gildeprint Drukkeri (2021).
21. Goodrich JK., et al. “Human genetics shape the gut microbiome”. Cell 4 (2014): 789-799.
22. Almeida A., et al. “A new genomic blueprint of the human gut microbiota”. Nature 7753 (2019): 499-504.
23. Vasieva O., et al. “A study on the analysis of personal gut, microbiomes”. Journal of Computer Science and Systems Biology 3 (2019): 71-79.
24. Naslund E and Hellstrom PM. “Appetite signalling: from gut peptide and enteric nerves to brain”. Physiology and Behavior 1-2 (2007): 256-262.
25. O’ Hara JR and Buret AG. “Mechanism of intestinal tight junctional disruption during infection”. Frontiers in Bioscience 13 (2008): 7008-7021.
26. Tim V., et al. “The role of hepatoglobin and its related protein, zonulin, in inflammatory bowel disease”. Tissue Barrie5 (2013): e27321.
27. Fasano A. “Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity and cancer”. Physiological Reviews 1 (2011): 151-175.
28. Vanuytsel T., et al. “The role of hepatoglobin and its related protein, zonulin, in inflammatory bowel disease”. Tissue Barriers5 (2013): e27321.
29. Lopetuso LR., et al. “The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors”. European Review for Medical and Pharmacological Sciences6 (2015): 1068-1076.
30. Ronald DH Jr., et al. “Gut microbiome: Profound implications for diet and disease”. Kompass Nutrition and Dietetics 1 (2023): 3-18.